a biopharmaceutical company to develop therapeutics for patients suffering from eczema
Industry Biotechnology
A.I.dvisor tells us that HOTH and PPTDF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HOTH and PPTDF's prices will move in lockstep.
Ticker / NAME | Correlation To HOTH | 1D Price Change % | ||
---|---|---|---|---|
HOTH | 100% | -2.87% | ||
PPTDF - HOTH | 28% Poorly correlated | N/A | ||
CRNX - HOTH | 28% Poorly correlated | +0.24% | ||
ABUS - HOTH | 28% Poorly correlated | +0.27% | ||
AXSM - HOTH | 26% Poorly correlated | -1.67% | ||
ATNM - HOTH | 24% Poorly correlated | -5.00% | ||
More |
Ticker / NAME | Correlation To HOTH | 1D Price Change % |
---|---|---|
HOTH | 100% | -2.87% |
therapeutics theme (53 stocks) | 22% Poorly correlated | -2.44% |
biopharmaceuticals theme (50 stocks) | 14% Poorly correlated | -2.47% |
pharmaceuticals theme (159 stocks) | 9% Poorly correlated | -1.94% |